Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains
Synthesis and biological evaluation of dihydroquinazoline-2-amines as potent non-nucleoside reverse transcriptase inhibitors of wild-type and mutant HIV-1 strains
复制标题
二氢喹唑啉-2-胺作为野生型和突变型 HIV-1 毒株的有效非核苷逆转录酶抑制剂的合成和生物学评价
DOI:
10.1016/j.ejmech.2019.05.011
复制
发表时间:
2019-08-15
影响因子:
6.7
通讯作者:
Chen, FenEr
中科院分区:
文献类型:
--
作者:
Jin, KaiJun;Sang, YaLi;Chen, FenEr
A novel series of dihydroquinazolin-2-amine derivatives were synthesized and evaluated for their anti HIV-1 activity in MT-4 cell cultures. All of the molecules were active against wild-type HIV-1 with EC50 values ranging from 0.61 mu M to 0.84 nM. The most potent inhibitor, compound 4b, had an EC50 value of 0.84 nM against HIV-1 strain 1118, and thus was more active than the reference drugs efavirenz and etravirine. Moreover, most of the compounds maintained high activity (low-micromolar EC50 values) against strains bearing the reverse transcriptase (RT) E138K mutation. Compound 4b had EC50 values of 3.5 nM and 66 nM against non-nucleoside reverse transcriptase inhibitor-resistant strains bearing the RT E138K and RES056 mutations. In enzyme activity assays, compound 4b exhibited an IC50 value of 10 nM against HIV-1 RT. Preliminary SARs and molecular docking studies provide valuable insights for further optimization. (C) 2019 Elsevier Masson SAS. All rights reserved.